kras mutation and glutathion The KRAS-G12D induces metabolic vulnerability in B-cell acute lymphoblastic leukemia KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Impact of KRAS mutation on the tumor microenvironment in colorectal cancer Targeting mutated GTPase KRAS in tumor therapies ScienceDirect
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



